What Is Genetic Penetrance? Its Effects on Cancer Risk and Clinical Applications

Cancer genetics has undergone a major transformation in recent years. Multigene panel tests offer a fast and accessible solution by testing many cancer susceptibility genes at the same time. This makes it possible to identify individuals carrying pathogenic germline (inherited) mutations in genes such as BRCA1-2, ATM, and PALB2 and provide them with genetic counseling on management strategies to reduce cancer risk. However, this process requires an accurate understanding and assessment of penetrance . Penetrance is the probability that a genotype's associated phenotype will develop, and accurate estimates of genetic risk are a cornerstone of personalized medicine.

What Is Penetrance?

In genetics, penetrance is the probability that a genetic mutation carried by an individual will cause a particular disease or phenotype in that individual. Simply put, it describes the proportion of people carrying a genetic mutation who develop the associated symptoms or disease.

Penetrance is usually expressed as a percentage. For example:

• If a mutation has 100% penetrance, every individual carrying that mutation will develop the associated disease.
• 50% penetrance means that only half of the individuals carrying the mutation will develop the disease.

The History of Cancer Genetics and the Importance of Multigene Panel Tests

Cancer genetics became an important scientific field as understanding of the genetic basis of cancer began to emerge in the mid-20th century. The discovery of oncogenes and tumor suppressor genes in the 1970s was a turning point in defining cancer as a genetic disease. In particular, identifying the BRCA1 and BRCA2 genes in the 1990s revolutionized the understanding of hereditary cancer risk. In subsequent years, advances in next-generation sequencing (NGS) technology expanded cancer genetics research by improving the speed and cost-effectiveness of genetic analyses. Multigene panel tests, a product of these technologies, allow many cancer susceptibility genes to be tested simultaneously. They have become a critical tool for the early diagnosis and management of hereditary cancers, particularly hereditary breast and ovarian cancer syndromes. Identifying patients' genetic risks enables preventive health strategies to be implemented for both individuals and their families.

The Effects of Penetrance on Genetic Counseling and Personalized Medicine

Penetrance is the probability that a genotype will produce its associated phenotype and plays a critical role in understanding individuals' disease risk during genetic counseling.

Genotype is the totality of DNA sequences in an individual's genetic material and forms the basis of inherited characteristics. Phenotype refers to the observable physical, biochemical and behavioral characteristics determined by this genetic material together with environmental influences.

Mutations in genes such as BRCA1 and BRCA2 increase an individual's risk of breast and ovarian cancer. However, particular subtypes or mutation types in these genes can substantially alter penetrance. For example, some BRCA1 mutation variants are associated with a higher risk, whereas others carry a lower risk. Penetrance can change with age and can also vary according to the type of genetic variant, the individual's family history and environmental factors. This requires more individualized risk estimates in genetic counseling and helps guide people toward appropriate screening and prevention strategies.

Understanding Penetrance: Complete, Incomplete and Age-Dependent Penetrance

Complete penetrance describes situations in which disease develops in everyone carrying a particular genetic variant. In most cases, however, penetrance is incomplete: people may carry a genetic risk without developing disease. BRCA1 and BRCA2 mutations provide examples of age-dependent penetrance: the risk of developing breast cancer by age 70 is 57-65% for people carrying a BRCA1 mutation, compared with 45-49% for a BRCA2 mutation. Different subtypes of BRCA mutations can also increase or decrease the risk of disease. For example, particular BRCA1 mutations may be associated with more aggressive cancers, while others may be linked to a lower risk. These differences highlight the importance of penetrance in personalized medicine: treatment plans and preventive interventions can be optimized according to the specific characteristics of the genetic variant.

Calculating Penetrance Mathematically

Mathematically, penetrance is expressed as follows:

$P = \frac{N_{\text{phenotype}}}{N_{\text{genotype}}}$

In this equation:

• $P$is the penetrance rate,
• $N_{\text{phenotype}}$ is the number of individuals who exhibit the phenotype among those with the genotype,
• $N_{\text{genotype}}$​ is the total number of individuals with the relevant genotype.

Example: If 60 of 100 individuals with a genotype exhibit a particular disease phenotype, the penetrance of that genotype is:

$P=\frac{60}{100}=0.6$

$P = \frac{60}{100} = 0.6 \, (i.e. \, 60$That is, 60%

Age-Dependent Penetrance and Changes Over Time

In some genetic conditions, penetrance changes with age. In this case, it is treated as an age-specific function and calculated over an age range.

Age-dependent penetrance analyses are often modeled using statistical techniques such as the Kaplan-Meier method or logistic regression. These approaches can incorporate the effects of environmental factors and family history alongside genetic data.

The Most Common Methods for Determining Penetrance

Calculating penetrance, particularly for rare genetic variants, requires large population datasets and advanced statistical methods. The following approaches are commonly used to estimate penetrance today:

1. Bayesian Modeling: Integrates different penetrance values from the literature to reduce uncertainty between genotype and phenotype.
2. Population-Based Approaches: Penetrance estimates are made by collecting genotype and phenotype data from large, diverse populations. This approach provides a broader perspective on the effects of genetic variants across the population. However, data collection and analysis can be time-consuming and costly.
3. Pedigree Analyses: Family pedigrees are examined to assess phenotypic expression in individuals carrying a particular genotype. This is a fundamental tool for understanding the distribution and penetrance of inherited diseases within families. However, it has limitations such as small sample sizes and the influence of environmental factors.
4. Molecular Genetic Tests: Advanced DNA analysis techniques are used to examine individuals' genetic profiles in detail. This allows specific genetic variants to be identified and their phenotypic effects to be assessed directly. However, interpreting genetic tests can be complex and may require additional expertise.

The accuracy of penetrance calculations can be influenced by variables such as interactions between a genetic variant and environmental factors, demographic characteristics including sex and age, and genetic modifications. Penetrance estimates should therefore be considered within a comprehensive framework for individualized risk management.

Genetic Modifiers and Polygenic Risk Scores: The BRCA1/BRCA2 Example

Genetic modifiers are factors that influence the phenotypic expression of a genotype and regulate the contribution of genetic variation to disease risk. A good example relating to the BRCA1 and BRCA2 genes is polygenic risk scores (PRS). Although individuals with BRCA1/BRCA2 mutations have a substantially increased risk of breast and ovarian cancer, PRS can help define their risk more precisely. PRS measure the combined effect of many small-effect variants, usually identified through genome-wide association studies (GWAS) in the general population. For example, a high PRS in individuals carrying a BRCA mutation may increase risk to around 80%, whereas a low PRS may reduce it to around 50%.

Clinically, incorporating PRS substantially influences genetic counseling and individualized risk management strategies. For example, BRCA carriers with a high PRS may be guided toward more intensive screening and preventive surgery, while less invasive approaches may be preferred for those with a low PRS. Integrating polygenic risk scores can also improve genetic risk estimates, even in people without a family history, and reduce unnecessary interventions. This shows that genetic modifiers can be used effectively in both individual risk prediction and population health approaches.

The Role of Mosaicism in Genetic Diseases and Example Cases

Mosaicism is the presence of genetically distinct cell populations within an individual and has a major influence on the penetrance and expressivity of genetic diseases.

Mosaicism generally arises from postzygotic mutations during embryonic development. For example, in segmental neurofibromatosis type 1, mosaicism causes signs of the disease to appear only in particular regions of the body. By contrast, if the same mutation is present in the germline, the individual may exhibit a much more severe phenotype overall. Mosaicism has substantial implications for genetic counseling because a mutation present in mosaic form may not be passed to an individual's children unless it is also carried in the germline.

A more striking example has been observed in overgrowth disorders such as Proteus syndrome. This syndrome is associated with a mosaic mutation in the AKT1 gene. When this mutation occurs early in embryonic development, it causes Proteus syndrome, which is characterized by severe deformities. However, the same mutation in the germline is usually fatal to the embryo. Similarly, mosaic mutations in the CXCR4 gene can attenuate the phenotype in WHIM syndrome and have a major impact on clinical outcomes. Although this dynamic nature of mosaicism complicates genetic counseling, it provides valuable insights into disease mechanisms and the identification of new treatment targets.

Factors Affecting Penetrance: Genetic and Environmental Influences

Many factors influence penetrance, including genetic modifiers, environmental factors and epigenetic mechanisms.

Genetic Modifiers

Genetic modifiers can increase or decrease a genetic variant's effect on the phenotype. For example:

• Polygenic Risk Scores (PRS): Among BRCA1/2 carriers, those with a high polygenic risk score are more likely to develop breast cancer.
• Cis- and Trans-Regulatory Factors: Variants in regulatory regions can alter penetrance by affecting the expression levels of particular genes.

Environmental Factors

Environmental factors can influence the translation of genetic risk into a phenotype. For example:

• Smoking: The risk of lung cancer may increase in individuals carrying a TP53 mutation.
• Diet and Physical Activity: Dietary and exercise habits can influence colorectal cancer risk in people with Lynch syndrome.

Epigenetic Mechanisms

Epigenetic changes, such as DNA methylation and histone modifications, can attenuate or exacerbate the effects of genetic variants. For example, epigenetic changes have been shown to affect the number and size of neurofibromas in people carrying an NF1 mutation.

Clinical Applications and Genetic Counseling

Penetrance estimates provide critical information for genetic counseling and personalized medicine:

• Risk-Reducing Surgery and Treatments: Recommendations for prophylactic mastectomy in BRCA1 carriers.
• Screening Programs: Early diagnosis and prevention strategies for carriers of highly penetrant genetic variants.

Future Research Areas

An in-depth understanding of genetic penetrance plays a critical role in determining how genetic variants contribute to disease risk. Modern research in this field is advancing through the integration of saturation genome studies and genome-editing technologies such as CRISPR-Cas9.

• Saturation Genome Studies and CRISPR-Cas9 Technology: Saturation genome studies involve systematically generating and analyzing all possible mutations in a particular gene or genomic region. By assessing the phenotypic effect of each mutation, this approach helps determine the functional consequences and penetrance of genetic variants. CRISPR-Cas9 is a powerful gene-editing tool that can make specific changes at targeted genomic sites. By studying the functional effects of particular genetic variants in vitro and in vivo, this technology makes it possible to understand their penetrance and association with disease. For example, cell or animal models generated using CRISPR-Cas9 allow detailed study of the phenotypic consequences of particular mutations and their interactions with environmental factors. CRISPR-Cas9 is also being considered as a potential tool for treating genetic diseases. However, the ethical, safety and regulatory implications of these gene-editing applications must be considered carefully.
• Future Research Directions: Expanding penetrance research requires the study of larger and more diverse population cohorts. In particular, whole-genome sequencing (WGS) technologies allow all of an individual's genetic material to be examined. This comprehensive approach enables rare and novel genetic variants to be detected. However, additional bioinformatics analyses and laboratory experiments are needed to determine their functional effects and relationships with disease. Faster, more cost-effective analysis of WGS data in the future will contribute to more accurate penetrance estimates. Machine learning and artificial intelligence also provide powerful tools for processing large genetic datasets and identifying genotype–phenotype relationships. These methods are used effectively, particularly to calculate polygenic risk scores and predict individual disease risks. As more sophisticated algorithms are developed, penetrance estimates will become more precise and personalized medicine will become more effective.

In conclusion, saturation genome studies and advanced genome-editing technologies such as CRISPR-Cas9 are critical to a deeper understanding of genetic penetrance and to elucidating the mechanisms of genetic diseases. Integrating these technologies facilitates the identification of genetic variants' functional effects, improving the effectiveness of genetic counseling and personalized medicine.

Conclusion: The Need for a More Complex Approach

Incomplete penetrance and variable expression create major challenges for accurately classifying genetic variants and for diagnosing and managing genetic diseases. Future studies should focus on better understanding the mechanisms of genetic and environmental interactions. This will enable more effective and precise approaches in both clinical practice and research.